A $100 million matching grant from the Weill Family Foundation is supporting the launch of the Weill Cancer Hub West—a collaboration between the UCSF Helen Diller Family Comprehensive Cancer Center and the Stanford Cancer Institute—set up to accelerate discoveries and speed the development of innovative new treatments for patients.
A blood test could map the complex ecosystem surrounding cancer cells, offering a more accurate way to predict which patients will benefit from immunotherapy, according to researchers at Mayo Clinic and Stanford Medicine. The test they developed could help guide treatment decisions across multiple cancer types and treatments.
